SP 500 Climbs as Tech Surge Offsets Energy and Staples Weakness Wall Street Futures Point to Fifth Consecutive Session of Gains as AI Optimism and Falling Oil Prices Lift Sentiment Kevin Warshs Potential Federal Reserve Overhaul Targets Wall Streets Market Plumbing Windex Understanding Product Limitations and Consumer Guidance for SC Johnsons Leading Glass Cleaner Kingfisher Shares Rise as BQ Owner Weathers Easter Sales Dip Eyes Heatwave Boost Ground Beef Prices Hit Record High Ahead of Memorial Day Adding Inflation Pressure on Consumers BATRA Q1 2026 Earnings NarrowerThanExpected Loss as Braves Navigate Seasonality CW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency MITK Q1 2026 Earnings EPS Beat Sent Shares Higher Amid Strong Operational Execution Paramount Skydance Corporation PSKY Q1 2026 Earnings EPS Surges Past Expectations Stock Rises TRS Q1 2026 Earnings EPS Beats Estimates by 2539 Clipper Realty Inc CLPR Q1 2026 Earnings Profitability Achieved Amid Market Headwinds Yalla Group Limited YALA Holds Steady at 620 Amid Modest Gains KKRS Holds Near Key Support as Subordinated Note Creeps Higher Backblaze Inc BLZE Slips 238 as Stock Tests Key Support Near 720 Markel Group Holds Steady Near 1859 Amid Tight Trading Range MKL Silexion Therapeutics Warrant SLXNW Slips Further as Market Weighs Uncertain Path Ashiana Housing Reports Flat Q4 Profit at Rs 21 Crore Revenue Climbs to Rs 335 Crore FY26 Earnings Surge VVOS Q1 2026 Earnings Wider EPS Loss Reflects Investment Phase Stock Edges Higher Flaherty Crumrine Preferred and Income Fund PFD Edges Lower Amid Modest Trading C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress HRTG Q1 2026 Earnings EPS Misses Estimates as Underwriting Pressures Persist Impinj Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher ADUS Q1 2026 Earnings EPS Beat Amidst Revenue Disclosure Gap Stock Edges Lower Prudential Financial Q1 2026 Earnings EPS Exceeds Expectations by 154 CODA Q1 2026 Earnings EPS Beats Estimates by 2658 as Company Maintains Profitability ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline